Stryker Addresses FDA Concerns
KALAMAZOO, MI-The FDA has informed Stryker Corp. that it has sufficiently addressed issues raised in a 2007 warning letter. Stryker received the letter regarding compliance with certain quality system requirements at its reconstructive implant manufacturing facility in Mahwah, NJ, in 2007.MORE
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
